Leonieke J. Van Mens
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Dual impact of interleukin-17 A blockade on inflammatory and stromal pathways in peripheral spondyloarthritis.
Journal: Arthritis research & therapy
Published: March 16, 2025
Young-GRAPPA 2023: The Future Is Bright.
Journal: The Journal of rheumatology
Published: March 06, 2024
Young-GRAPPA (Y-GRAPPA) at the 2022 GRAPPA Annual Meeting: One Year in Y-GRAPPA. Where Do We Stand, Where Do We Go?
Journal: The Journal of rheumatology
Published: May 30, 2023
Treatment decisions in axial spondyloarthritis daily clinical practice are more than treat-to-target.
Journal: Rheumatology (Oxford, England)
Published: December 06, 2022
Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force.
Journal: RMD open
Published: June 17, 2022
Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting.
Journal: The Journal of rheumatology
Published: December 07, 2021
Young-GRAPPA at the Annual GRAPPA Meeting: Presentation of a New Group Within GRAPPA and Its Vision.
Young-GRAPPA at the Annual GRAPPA Meeting: Presentation of a New Group Within GRAPPA and Its Vision.
Journal: The Journal of rheumatology
Published: December 07, 2021
Gender equity in academic rheumatology: is there a gender gap at European rheumatology conferences?
Journal: RMD open
Published: November 27, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting.
Journal: The Journal of rheumatology. Supplement
Published: June 02, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting.
Journal: The Journal of rheumatology
Published: February 16, 2021
IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt.
Journal: Frontiers in immunology
Published: September 29, 2020
Anti-IL-17A treatment reduces serum inflammatory, angiogenic and tissue remodeling biomarkers accompanied by less synovial high endothelial venules in peripheral spondyloarthritis.
Journal: Scientific reports
Published: August 18, 2020
Last Updated: 09/26/2026